MORGAN HUMAN SYSTEMS LTD
Company registration number 12402874 (England and Wales)
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
PAGES FOR FILING WITH REGISTRAR
MORGAN HUMAN SYSTEMS LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MORGAN HUMAN SYSTEMS LTD
BALANCE SHEET
AS AT
31 JANUARY 2026
31 January 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
3
25,591
31,909
Biological assets
4
3,344
1,155
Investments
5
34,301
29,100
63,236
62,164
Current assets
Debtors
6
122,058
79,702
Cash at bank and in hand
132,263
279,648
254,321
359,350
Creditors: amounts falling due within one year
7
(113,190)
(186,040)
Net current assets
141,131
173,310
Total assets less current liabilities
204,367
235,474
Provisions for liabilities
(575)
(876)
Net assets
203,792
234,598
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
203,692
234,498
Total equity
203,792
234,598
MORGAN HUMAN SYSTEMS LTD
BALANCE SHEET (CONTINUED)
AS AT
31 JANUARY 2026
31 January 2026
- 2 -

For the financial year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 11 June 2026
Dr L J Morgan
Director
Company registration number 12402874 (England and Wales)
MORGAN HUMAN SYSTEMS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
- 3 -
1
Accounting policies
Company information

Morgan Human Systems Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 1 Brassey Road, Old Potts Way, Shrewsbury, Shropshire, SY3 7FA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% Reducing balance
Computers
25% Reducing balance
Motor vehicles
25% Reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Biological assets

Biological assets are recognised only when three recognition criteria have been fulfilled:

- the entity has control over the asset as a result of past events;

- it is probable that future economic benefits associated with the asset will flow to the entity; and

- the fair value or cost of the asset can be measured reliably.

The company measures biological assets at cost less accumulated depreciation and accumulated impairment losses.
No depreciation is provided on biological assets.
MORGAN HUMAN SYSTEMS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 4 -
1.5
Fixed asset investments

Investments are initially measured at transaction price excluding transaction costs, and are subsequently measured at fair value at each reporting date. Transaction costs are expensed to profit or loss as incurred. Changes in fair value are recognised through the profit and loss account.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

MORGAN HUMAN SYSTEMS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 5 -
1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
2
1
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 February 2025
50,173
Additions
2,039
At 31 January 2026
52,212
Depreciation and impairment
At 1 February 2025
18,264
Depreciation charged in the year
8,357
At 31 January 2026
26,621
Carrying amount
At 31 January 2026
25,591
At 31 January 2025
31,909
MORGAN HUMAN SYSTEMS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 6 -
4
Biological assets
Sheep
£
Cost
At 1 February 2025
1,155
Additions - purchases
2,189
At 31 January 2026
3,344
Depreciation and impairment
At 1 February 2025 and 31 January 2026
-
0
Carrying amount
At 31 January 2026
3,344
At 31 January 2025
1,155
5
Fixed asset investments
2026
2025
£
£
Other investments other than loans
34,301
29,100
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 February 2025
29,100
Additions
5,201
At 31 January 2026
34,301
Carrying amount
At 31 January 2026
34,301
At 31 January 2025
29,100
6
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
104,039
78,900
Other debtors
18,019
802
122,058
79,702
MORGAN HUMAN SYSTEMS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 7 -
7
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
1,978
391
Taxation and social security
32,211
88,214
Other creditors
79,001
97,435
113,190
186,040
2026-01-31 2025-02-01 false false false 01 July 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Dr L J Morgan 12402874 2025-02-01 2026-01-31 12402874 2026-01-31 12402874 2025-01-31 12402874 core:CurrentFinancialInstruments core:WithinOneYear 2026-01-31 12402874 core:CurrentFinancialInstruments core:WithinOneYear 2025-01-31 12402874 core:CurrentFinancialInstruments 2026-01-31 12402874 core:CurrentFinancialInstruments 2025-01-31 12402874 core:ShareCapital 2026-01-31 12402874 core:ShareCapital 2025-01-31 12402874 core:RetainedEarningsAccumulatedLosses 2026-01-31 12402874 core:RetainedEarningsAccumulatedLosses 2025-01-31 12402874 bus:Director1 2025-02-01 2026-01-31 12402874 core:FurnitureFittings 2025-02-01 2026-01-31 12402874 core:ComputerEquipment 2025-02-01 2026-01-31 12402874 core:MotorVehicles 2025-02-01 2026-01-31 12402874 2024-02-01 2025-01-31 12402874 core:OtherPropertyPlantEquipment 2025-01-31 12402874 core:OtherPropertyPlantEquipment 2026-01-31 12402874 core:OtherPropertyPlantEquipment 2025-02-01 2026-01-31 12402874 core:OtherPropertyPlantEquipment 2025-01-31 12402874 core:BearerBiologicalAssetClass2 2025-02-01 2026-01-31 12402874 core:BearerBiologicalAssetClass2 2025-01-31 12402874 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 12402874 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 12402874 bus:FRS102 2025-02-01 2026-01-31 12402874 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 12402874 bus:FullAccounts 2025-02-01 2026-01-31 xbrli:pure xbrli:shares iso4217:GBP